EcoVadis2026
Inke
Pharmaceutical industry · EcoVadis consulting
- Client
- Inke
- Sector
- Pharmaceutical industry (active ingredients)
- Size
- 2 manufacturing sites in Spain
- Mission type
- EcoVadis consulting
- Duration
- 2025 to 2026
Context & objectives
Based in Barcelona, Inke develops and manufactures active pharmaceutical ingredients for inhalation, ophthalmic and central nervous system therapies, for customers in more than 40 countries. In July 2025, its EcoVadis assessment (size M questionnaire) scored 61/100. The goal: a clear step up at the next reassessment.
Our approach
- Scorecard diagnostic and a prioritised action plan
- Support in improving the core documentation
- Support in completing the questionnaire
Key results
- 80/100 in September 2026, up from 61/100 in July 2025: +19 points
- Silver medal
- Stronger core documentation, ready for the next assessments
At 80/100, the Silver medal places the company among the top 15% of its reference population. Medals depend on the percentile reached at the time of assessment: why the same score can earn a different medal.
